Statin Therapy and Risk of Polyneuropathy in Type 2 Diabetes: A Danish Cohort Study

Danish cohort study found statin therapy unlikely to increase/mitigate polyneuropathy risk in patients with type 2 diabetes (incidence rate events per 1,000 person-years was similar in new users (4.0 [95% CI 3.8–4.2]), prevalent users (3.8 [3.6–3.9]) and nonusers (3.8 [3.7–4.0]).

Diabetes Care